Most of the presented research article summaries were created by the EHDN
science writer Diana Raffelsbauer, on behalf of the EHDN Newsletter Editorial Board.
EHDN aims to inform the lay community and healthcare professionals about current efforts and progress towards finding a cure for Huntington’s disease.
Serines 13 and 16 are critical determinants
of full-length human
mutant huntingtin induced disease
pathogenesis in HD mice
Xiaofeng Gu et al.am06-jun2010-issue10-en
| |Intrabody gene therapy ameliorates
motor, cognitive, and neuropathological
symptoms in multiple mouse
models of Huntington’s disease
Amber L. Southwell et al.am03-mar2010-issue09-en
Two studies paving the way to
allele-specific RNA interference
therapy for Huntington’s disease
Maria S. Lombardi et al.
Edith L. Pfister et al.am02-mar2010-issue09-en
Motor abnormalities in premanifest
persons with Huntington’s
disease: the PREDICT-HD study
K. Biglan et al.am01-mar2010-issue09-en